FDA Drug Application (205825) for MEMANTINE HYDROCHLORIDE by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number205825
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage7MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMEMANTINE HYDROCHLORIDE
Active IngredientMEMANTINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MEMANTINE HYDROCHLORIDE4


Back to FDA Applications sponsored by AMNEAL PHARMS